
CERVisure offers an AI-powered DNA Ploidy test for early detection and prevention of cervical cancer. The test involves a simple three-step process: sample collection, AI-driven analysis of DNA content to identify abnormalities, and a final report reviewed by experts. Cervical cancer is a significant global health issue, particularly in India, often asymptomatic in its early stages and largely caused by persistent HPV infections. CERVisure's non-invasive DNA Ploidy scan aims to detect cancerous changes much earlier than traditional methods, providing insights into genetic instability, enabling proactive prevention, and facilitating personalized treatment planning. The company's mission is to eliminate cervical cancer by providing accessible, innovative DNA-based screening technologies.

CERVisure offers an AI-powered DNA Ploidy test for early detection and prevention of cervical cancer. The test involves a simple three-step process: sample collection, AI-driven analysis of DNA content to identify abnormalities, and a final report reviewed by experts. Cervical cancer is a significant global health issue, particularly in India, often asymptomatic in its early stages and largely caused by persistent HPV infections. CERVisure's non-invasive DNA Ploidy scan aims to detect cancerous changes much earlier than traditional methods, providing insights into genetic instability, enabling proactive prevention, and facilitating personalized treatment planning. The company's mission is to eliminate cervical cancer by providing accessible, innovative DNA-based screening technologies.